Maxia Strategies holds a Swiss establishment license for the import and release of medicinal products. Our licensing division helps companies outside Switzerland bring their products to Swiss patients faster. We support all standard marketing authorization procedures, including accelerated pathways and regulatory reliance programs. We provide product quality oversight, pharmacovigilance (local safety operator) and related Marketing Authorization Holder services.